• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Ascensia looks to expand access to blood glucose monitoring tech for UnitedHealthcare enrollees

April 5, 2018 By Sarah Faulkner

Ascensia Diabetes Care inked a new relationship with UnitedHealthcare (NYSE:UNH), the company touted today, which is designed to improve access to Ascensia’s Contour Next blood glucose meters and test strips for UnitedHealthcare members.

Now, people enrolled in UnitedHealthcare’s employer or commercial plans can get a meter or test trip through their pharmacy benefit at a Tier 2 copay level, according to the Switzerland-based company.

Before Ascensia established its new relationship with the insurer, members could only access the Contour Next portfolio with prior authorization approved by their plan.

“We are working together with UnitedHealthcare to help their members with diabetes obtain the highly-accurate Contour Next test strips and meters so that they can effectively manage their diabetes,” Robert Schumm, VP & managing director of Ascensia’s U.S. business, said in prepared remarks. “This change will give more people the opportunity to access these products and at a reasonable cost.”

Earlier this year, Ascensia expanded its partnership with Insulet (NSDQ:PODD) to include a global commercial deal. The two companies inked a world-wide development agreement in June last year to connect Ascensia’s Contour Next One blood glucose monitor with Insulet’s next-gen Omnipod system, Omnipod Dash.

According to the terms of the non-exclusive commercial deal, Insulet plans to distribute the Contour Next One meter and test strips with the Omnipod Dash insulin delivery system.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, Patient Monitoring, Wall Street Beat Tagged With: Ascensia Diabetes Care, unitedhealth

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS